It is a veterinary private limited company based in Delhi, Delhi, India, established in 2016.
2016 | Delhi, Delhi, India | ActivePleiadian Pharma Private Limited, a active private limited company, was established on 15 July 2016 in Delhi, Delhi, India. Engaging in animal health services within the veterinary sector, it holds CIN: U85200DL2016PTC303086. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Anil Kumar Agrawal (Director), Ajay Kumar Agrawal (Director), Asim Kumar Agrawal (Director). Past directors included Anil Kumar Agrawal, Ajay Kumar Agrawal, Rajneesh Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-5, Second Floor, Shiva Chamber, Nimri Colony Commercial Complex, Ashok Vihar, Phase-4, Delhi, Delhi, 110052.
U85200DL2016PTC303086
303086
15 July 2016
₹0.20 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Pleiadian Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Agrawal | Director | 13 Sep 2018 | Current |
| Ajay Kumar Agrawal | Director | 13 Sep 2018 | Current |
| Asim Kumar Agrawal | Director | 13 Sep 2018 | Current |
| Eshwar Prasad Jumpala | Director | 13 Sep 2018 | Current |
| Sanket Kumar Agrawal | Director | 13 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 05 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 05 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Pleiadian Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Pleiadian Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pleiadian Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pleiadian Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pleiadian Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pleiadian Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Pleiadian Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Anil Kumar Agrawal was appointed as a Director was appointed as a Director on 13 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The activity Ajay Kumar Agrawal was appointed as a Director was appointed as a Director on 13 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The activity Asim Kumar Agrawal was appointed as a Director was appointed as a Director on 13 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The activity Eshwar Prasad Jumpala was appointed as a Director was appointed as a Director on 13 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The CIN of Pleiadian Pharma Private Limited is U85200DL2016PTC303086.
Pleiadian Pharma Private Limited is headquartered at B-5, Second Floor, Shiva Chamber, Nimri Colony Commercial Complex, Ashok Vihar, Phase-4, Delhi, Delhi, 110052.
Pleiadian Pharma Private Limited was incorporated on 15 July 2016.
The current directors of Pleiadian Pharma Private Limited are
The primary industry of Pleiadian Pharma Private Limited is Veterinary.
Pleiadian Pharma Private Limited is unlisted.
The authorized capital of Pleiadian Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
The compliance status of Pleiadian Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX